Agency Information Collection Activities; Proposed eCollection eComments Requested; Submission for OMB Approval: U.S. Official Order Forms-Schedules I & II (DEA Form 222), 56404 [2014-22353]

Download as PDF 56404 Federal Register / Vol. 79, No. 182 / Friday, September 19, 2014 / Notices respond: An estimated 2,500 respondents will take 5 minutes to complete the form. (6) An estimate of the total public burden (in hours) associated with the collection: The estimated annual public burden associated with this collection is 208 hours. If additional information is required contact: Jerri Murray, Department Clearance Officer, United States Department of Justice, Justice Management Division, Policy and Planning Staff, Two Constitution Square, 145 N Street NE., Room 3E– 405B, Washington, DC 20530. Dated: September 16, 2014. Jerri Murray, Department Clearance Officer for PRA, U.S. Department of Justice. [FR Doc. 2014–22352 Filed 9–18–14; 8:45 am] BILLING CODE 4410–FY–P DEPARTMENT OF JUSTICE [OMB Number 1117–0010] Agency Information Collection Activities; Proposed eCollection eComments Requested; Submission for OMB Approval: U.S. Official Order Forms—Schedules I & II (DEA Form 222) Drug Enforcement Administration, Department of Justice. ACTION: 30-Day notice. AGENCY: The Department of Justice (DOJ), Drug Enforcement Administration (DEA), will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. This proposed information collection was previously published in the Federal Register at 79 FR, pages 41705–41706, July 17, 2014, allowing for a 60 day comment period. DATES: Comments are encouraged and will be accepted for an additional 30 days until October 20, 2014. FOR FURTHER INFORMATION CONTACT: If you have additional comments especially on the estimated public burden or associated response time, suggestions, or need a copy of the proposed information collection instrument with instructions or additional information, please contact Imelda Paredes, Office of Diversion Control, Drug Enforcement Administration, 8701 Morrissette Drive, Springfield, Virginia 22152. Written comments and/or suggestions can also be directed to the Office of Management tkelley on DSK3SPTVN1PROD with NOTICES SUMMARY: VerDate Sep<11>2014 17:15 Sep 18, 2014 Jkt 232001 and Budget, Office of Information and Regulatory Affairs, Attention Department of Justice Desk Officer, Washington, DC 20530 or sent to OIRA_ submisisons@omb.eop.gov. SUPPLEMENTARY INFORMATION: Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should address one or more of the following four points: —Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the Drug Enforcement Administration, including whether the information will have practical utility; —Evaluate the accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; —Enhance the quality, utility, and clarity of the information to be collected; and/or —Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses. Overview of this information collection: 1. Type of Information Collection: Extension of a currently approved collection. 2. The Title of the Form/Collection: U.S. Official Order Forms—Schedules I & II. 3. The agency form number: DEA Form 222. 4. Affected public who will be asked or required to respond, as well as a brief abstract: Primary: Business or other for-profit. Other: Not-for-profit, Federal, State, local, or tribal government. Abstract: The Controlled Substances Act (CSA) (21 U.S.C. 801–971) requires the Drug Enforcement Administration (DEA) to establish a closed system of distribution for substances that have a potential for abuse. Section 828 of the CSA mandates that no person may distribute a controlled substance in schedule I or II except in response to an order issued on a DEA provided form. The DEA regulations implementing 21 U.S.C. 828 can be found in 21 CFR part 1305. 5. An estimate of the total number of respondents and the amount of time estimated for an average respondent to PO 00000 Frm 00070 Fmt 4703 Sfmt 4703 respond: The DEA estimates that 152,609 registrants participate in this information collection, taking an estimated 6.17 hours per registrant annually. 6. An estimate of the total public burden (in hours) associated with the collection: 942,315 annual burden hours. If additional information is required contact: Jerri Murray, Department Clearance Officer, United States Department of Justice, Justice Management Division, Policy and Planning Staff, Two Constitution Square, 145 N Street NE., 3E.405B, Washington, DC 20530. Dated: September 16, 2014. Jerri Murray, Department Clearance Officer for PRA, U.S. Department of Justice. [FR Doc. 2014–22353 Filed 9–18–14; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Antitrust Division Notice Pursuant to the National Cooperative Research and Production Act of 1993—Cable Television Laboratories, Inc. Notice is hereby given that, on August 14, 2014, pursuant to Section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (‘‘the Act’’), Cable Television Laboratories, Inc. (‘‘CableLabs’’) has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership. The notifications were filed for the purpose of extending the Act’s provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, Jiangsu Broadcasting Cable Information Network Corp. Ltd., Nanjing, PEOPLE’S REPUBLIC OF CHINA; Beijing Gehua CATV Co. Ltd., Beijing, PEOPLE’S REPUBLIC OF CHINA; and Vyve Broadband LLC, Purchase, NY, have been added as parties to this venture. No other changes have been made in either the membership or planned activity of the group research project. Membership in this group research project remains open, and CableLabs intends to file additional written notifications disclosing all changes in membership. On August 8, 1988, CableLabs filed its original notification pursuant to Section 6(a) of the Act. The Department of Justice published a notice in the Federal E:\FR\FM\19SEN1.SGM 19SEN1

Agencies

[Federal Register Volume 79, Number 182 (Friday, September 19, 2014)]
[Notices]
[Page 56404]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-22353]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

[OMB Number 1117-0010]


Agency Information Collection Activities; Proposed eCollection 
eComments Requested; Submission for OMB Approval: U.S. Official Order 
Forms--Schedules I & II (DEA Form 222)

AGENCY: Drug Enforcement Administration, Department of Justice.

ACTION: 30-Day notice.

-----------------------------------------------------------------------

SUMMARY: The Department of Justice (DOJ), Drug Enforcement 
Administration (DEA), will be submitting the following information 
collection request to the Office of Management and Budget (OMB) for 
review and approval in accordance with the Paperwork Reduction Act of 
1995. This proposed information collection was previously published in 
the Federal Register at 79 FR, pages 41705-41706, July 17, 2014, 
allowing for a 60 day comment period.

DATES: Comments are encouraged and will be accepted for an additional 
30 days until October 20, 2014.

FOR FURTHER INFORMATION CONTACT: If you have additional comments 
especially on the estimated public burden or associated response time, 
suggestions, or need a copy of the proposed information collection 
instrument with instructions or additional information, please contact 
Imelda Paredes, Office of Diversion Control, Drug Enforcement 
Administration, 8701 Morrissette Drive, Springfield, Virginia 22152. 
Written comments and/or suggestions can also be directed to the Office 
of Management and Budget, Office of Information and Regulatory Affairs, 
Attention Department of Justice Desk Officer, Washington, DC 20530 or 
sent to OIRAsubmisisons@omb.eop.gov.

SUPPLEMENTARY INFORMATION: Written comments and suggestions from the 
public and affected agencies concerning the proposed collection of 
information are encouraged. Your comments should address one or more of 
the following four points:

--Evaluate whether the proposed collection of information is necessary 
for the proper performance of the functions of the Drug Enforcement 
Administration, including whether the information will have practical 
utility;
--Evaluate the accuracy of the agency's estimate of the burden of the 
proposed collection of information, including the validity of the 
methodology and assumptions used;
--Enhance the quality, utility, and clarity of the information to be 
collected; and/or
--Minimize the burden of the collection of information on those who are 
to respond, including through the use of appropriate automated, 
electronic, mechanical, or other technological collection techniques or 
other forms of information technology, e.g., permitting electronic 
submission of responses.

    Overview of this information collection:
    1. Type of Information Collection: Extension of a currently 
approved collection.
    2. The Title of the Form/Collection: U.S. Official Order Forms--
Schedules I & II.
    3. The agency form number: DEA Form 222.
    4. Affected public who will be asked or required to respond, as 
well as a brief abstract:
    Primary: Business or other for-profit.
    Other: Not-for-profit, Federal, State, local, or tribal government.
    Abstract: The Controlled Substances Act (CSA) (21 U.S.C. 801-971) 
requires the Drug Enforcement Administration (DEA) to establish a 
closed system of distribution for substances that have a potential for 
abuse. Section 828 of the CSA mandates that no person may distribute a 
controlled substance in schedule I or II except in response to an order 
issued on a DEA provided form. The DEA regulations implementing 21 
U.S.C. 828 can be found in 21 CFR part 1305.
    5. An estimate of the total number of respondents and the amount of 
time estimated for an average respondent to respond: The DEA estimates 
that 152,609 registrants participate in this information collection, 
taking an estimated 6.17 hours per registrant annually.
    6. An estimate of the total public burden (in hours) associated 
with the collection: 942,315 annual burden hours.
    If additional information is required contact: Jerri Murray, 
Department Clearance Officer, United States Department of Justice, 
Justice Management Division, Policy and Planning Staff, Two 
Constitution Square, 145 N Street NE., 3E.405B, Washington, DC 20530.

    Dated: September 16, 2014.
Jerri Murray,
Department Clearance Officer for PRA, U.S. Department of Justice.
[FR Doc. 2014-22353 Filed 9-18-14; 8:45 am]
BILLING CODE 4410-09-P